A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088

Clinical trial NCT06579300 · TERMINATED

Trial details

NCT number: NCT06579300
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2024-09-04
Primary completion: 2025-09-03
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.